Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




PennyOmega.com Stock Report! 8/10/09, BNE, ALTH, ATEA, TWTC, PDE, WMT

Penny Omega (August 10th, 2009) Writes:

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

signup3m

 

Monday August 10, 2009

PennyOmega.com Stock Report!

**************************************************************

Bowne & Co., Inc. (NYSE: BNE), a global leader in shareholder and marketing communications services, today announced that Standard & Poor’s Ratings Service affirmed its ‘B’ corporate credit rating and revised the rating outlook to positive.

Allos Therapeutics, Inc. (Nasdaq: ALTH) announced today that the Company has received notification from the U.S. Food and Drug Administration’s (FDA) that the Oncologic Drugs Advisory Committee (ODAC) will hold a meeting on September 2, 2009, to review the Company’s New Drug Application (NDA) for pralatrexate for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

Astea International Inc. (Nasdaq:

...
Tags for this Post:
Allos Therapeutics Inc;, Asset Management, Astea International Inc., Bowne & Co. Inc., Chief Executive Officer, Chief Financial Officer, communications services, data networking solutions;, Engineering, Imran (Ron) Toufeeq, International Deepwater Division for R&B Falcon Corporation, John Tobin, Korea, Louis A. Raspino, Market Commentary, MPLS;, National Football League, Oncologic Drugs Advisory Committee, Operations, PennyOmega.com, peripheral T-cell lymphoma;, president, president and chief executive officer, Pride International Inc.;, R&B Falcon Corporation, Ratings Service, Rick Etskovitz, Senior Vice President, Standard & Poor, stock featured on our site;, Stocks to Watch, U.S. Food and Drug Administration, University of Houston, Vice President, VPN, Walmart, Wmt, Zack Bergreen

FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO

Bullish Bankers (June 5th, 2009) Writes:

Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars. The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), and pending re-submissions to the FDA for complete response rulings by the agency which require more information before an approval can be granted.

Allos Therapeutics [ALTH: 7.19, -0.13 (-1.78%)]: On 5/30/09 , ALTH updated data from the Company’s pivotal Phase 2 PROPEL study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). The overall response rate for pralatrexate as evaluated by central independent

...
Tags for this Post:
Allos Therapeutics Inc;, anemia, Astrazeneca, B-cell lymphomas;, Bladder Cancer, Brain Cancer, Breast Cancer, bullish bankers, cancer, Cancers, care for patients with advanced prostate cancer;, CDX-110;, CDX-1307;, CDX-1401;, CDX;, Chemotherapy, chemotherapy group;, CR011;, DM1;, Europe, Fda, Financial, Genentech Inc., Glioblastoma Multiforme, hematologic malignancies;, hypokalemia;, Lung Cancer, Lymphoma, Market Commentary, Melanoma, Mike Havrilla, Mucositis;, multiple myeloma, neutropenia;, OGX-011;, Pancreatic Cancer, pancreatic cancers;, pancreatitis, peripheral T-cell lymphoma;, Pfizer, Prostate Cancer, Roche Group;, Samuel Duffey;, small cell lung cancer, stomach cancer;, targeted population group;, therapeutic anti-cancer vaccine;, thrombocytopenia, treatment of advanced HER2-positive breast cancer;, treatment of melanoma;, treatment of metastatic breast cancer, tumor, tumors, United States

Zacks #1 Rank Additions for Monday – Zacks Tale of the Tape

Zacks Market Commentaries (February 23rd, 2009) Writes:

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Access National Corp (ANCX) Actuate Corp (ACTU) Alliance One International Inc (AOI) Allos Therapeutics Inc (ALTH) Amerisafe Inc (AMSF) Amtrust Financial Services Inc (AFSI) Anaren Inc (ANEN) AutoZone Inc (AZO) Baxter International Inc (BAX) Blackrock Kelso Capital Corp (BKCC) Briggs & Stratton Corp (BGG) Calumet Specialty Products Partners LP (CLMT) Chinacast Education Corp (CAST) Cyberonics Inc (CYBX) DCT Industrial Trust Inc (DCT) EZCORP Inc (EZPW) Fidelity National Financial Inc (FNF) Grupo Financiero Galicia SA (GGAL) HMS Holdings Corp (HMSY) Hormel Foods Corp (HRL) J&J Snack Foods Corp (JJSF) Javelin Pharmaceuticals Inc (JAV) Kindred Healthcare Inc (KND) Lundin Mining Corp (LMC) Magyar Telekom Plc (MTA) Medivation Inc (MDVN) Monro Muffler ...
Tags for this Post:
Access National Corp;, Actuate Corp;, Alliance One International Inc;, Allos Therapeutics Inc;, Amerisafe Inc, Amtrust Financial Services Inc;, Anaren Inc., AutoZone Inc., Baxter International Inc., Blackrock Kelso Capital Corp;, Briggs & Stratton Corp;, Calumet Specialty Products Partners LP;, Chinacast Education Corp;, Cyberonics Inc, DCT Industrial Trust Inc;, EZCORP Inc.;, Fidelity National Financial Inc, Grupo Financiero Galicia SA;, HMS Holdings Corp;, Hormel Foods Corp.;, J&J Snack Foods Corp;, Javelin Pharmaceuticals Inc.;, Kindred Healthcare Inc, Lundin Mining Corp;, Magyar Telekom Plc;, Medivation Inc, Monro Muffler Brake Inc;, New Jersey Resources Corp, Nidec Corp, Novavax Inc., Odyssey Healthcare Inc.;, Omega Navigation Enterprises Inc, Pennichuck Corp;, Petmed Express Inc., Poniard Pharmaceuticals Inc;, Rollins Inc;, Smith & Wesson Holding Corp;, Societe Generale SA, Southern Community Financial Corp;, Stocks to Watch, Telecom Italia SpA;, Transatlantic Holdings Inc;, Tucows Inc., US Geothermal Inc.;, Zacks Market Commentaries

Zacks #1 Rank Additions for Thursday – Zacks Tale of the Tape

Zacks Market Commentaries (February 12th, 2009) Writes:

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Acxiom Corp (ACXM) Koninklijke Ahold NV (AHONY) Allos Therapeutics Inc (ALTH) American Italian Pasta Co (AIPC) AsiaInfo Holdings Inc (ASIA) Broadridge Financial Solutions Inc (BR) CNS Response Inc (CNSO) Cosan Ltd (CZZ) Cray Inc (CRAY) CTI Industries Corp (CTIB) Cytokinetics Inc (CYTK) DTS Inc (DTSI) Enbridge Inc (ENB) Expedia Inc (EXPE) EZCORP Inc (EZPW) Flanders Corp (FLDR) Gamco Investors Inc (GBL) Inverness Medical Innovations Inc (IMA) INX Inc (INXI) Javelin Pharmaceuticals Inc (JAV) Majesco Entertainment Co (COOL) MAP Pharmaceuticals Inc (MAPP) Maxwell Technologies Inc (MXWL) Metavante Technologies Inc (MV) Monro Muffler Brake Inc (MNRO) Myriad Genetics Inc (MYGN) Onstream Media Corp (ONSM) PetMed Express Inc (PETS) Poniard ...
Tags for this Post:
Acxiom Corp;, Allos Therapeutics Inc;, American Italian Pasta Co, AsiaInfo Holdings Inc;, Broadridge Financial Solutions Inc.;, CNS Response Inc;, Cosan Ltd., Cray Inc;, CTI Industries Corp, Cytokinetics Inc;, DTS Inc., Enbridge Inc., Expedia Inc., EZCORP Inc.;, Flanders Corp;, Gamco Investors Inc;, Inverness Medical Innovations Inc.;, INX Inc;, Javelin Pharmaceuticals Inc.;, Koninklijke Ahold NV;, Majesco Entertainment Co, MAP Pharmaceuticals Inc.;, Maxwell Technologies Inc;, Metavante Technologies Inc;, Monro Muffler Brake Inc;, Myriad Genetics Inc., Onstream Media Corp., Petmed Express Inc., Poniard Pharmaceuticals Inc;, Powell Industries Inc.;, RADVISION Ltd;, Rollins Inc;, Royal Bank Of Scotland Group Plc, Stocks to Watch, Telecom Italia SpA;, Watson Pharmaceuticals Inc;, Zacks Market Commentaries

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.